Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1943 1
1945 1
1946 1
1949 1
1950 1
1951 1
1954 1
1958 1
1960 1
1962 4
1963 2
1964 1
1965 4
1966 3
1967 9
1968 4
1969 4
1970 1
1971 3
1972 3
1973 1
1974 1
1975 1
1993 1
1994 2
1996 1
1999 1
2001 1
2002 1
2004 4
2005 4
2006 14
2007 13
2008 12
2009 13
2010 19
2011 22
2012 20
2013 27
2014 24
2015 16
2016 33
2017 26
2018 13
2019 21
2020 26
2021 40
2022 36
2023 31
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Patil VM, et al. Among authors: purandare n. J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015. Epub 2022 Oct 20. J Clin Oncol. 2023. PMID: 36265101 Clinical Trial.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: purandare n. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
Systematic review and meta-analysis of prediction models used in cervical cancer.
Jha AK, Mithun S, Sherkhane UB, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L. Jha AK, et al. Among authors: purandare n. Artif Intell Med. 2023 May;139:102549. doi: 10.1016/j.artmed.2023.102549. Epub 2023 Apr 11. Artif Intell Med. 2023. PMID: 37100501 Free article. Review.
FIGO statement: Fertility preservation.
Henry L, Berek JS, Diaz I, Feldberg D, Mocanu E, Niederberger CC, Ohlander S, Purandare N, Rosenwaks Z, Tulandi T, Wasson M, Wilailak S, Malhotra J. Henry L, et al. Among authors: purandare n. Int J Gynaecol Obstet. 2023 Dec;163(3):790-794. doi: 10.1002/ijgo.15187. Epub 2023 Oct 9. Int J Gynaecol Obstet. 2023. PMID: 37807831 Free article.
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.
Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Noronha V, et al. Among authors: purandare n. J Clin Oncol. 2020 Jan 10;38(2):124-136. doi: 10.1200/JCO.19.01154. Epub 2019 Aug 14. J Clin Oncol. 2020. PMID: 31411950 Clinical Trial.
Conservative Management of Pelvic Organ Prolapse: Indian Contribution.
Ryan GA, Purandare NC, Ganeriwal SA, Purandare CN. Ryan GA, et al. Among authors: purandare nc. J Obstet Gynaecol India. 2021 Feb;71(1):3-10. doi: 10.1007/s13224-020-01406-5. Epub 2021 Jan 6. J Obstet Gynaecol India. 2021. PMID: 33814793 Free PMC article. Review.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: purandare n. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
MNRR1, a Biorganellar Regulator of Mitochondria.
Grossman LI, Purandare N, Arshad R, Gladyck S, Somayajulu M, Hüttemann M, Aras S. Grossman LI, et al. Among authors: purandare n. Oxid Med Cell Longev. 2017;2017:6739236. doi: 10.1155/2017/6739236. Epub 2017 Jun 8. Oxid Med Cell Longev. 2017. PMID: 28685009 Free PMC article. Review.
441 results